These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7669449)

  • 1. Calculation of an effect compartment rate constant using recovery indices obtained with an isolated arm technique.
    Shanks CA; Avram MJ; Krejcie TC; Henthorn TK
    Br J Anaesth; 1995 Jul; 75(1):109-12. PubMed ID: 7669449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of recovery index of rocuronium or vecuronium with simultaneously administered pancuronium in the isolated forearm.
    Fawcett WJ; Fauvel NJ; Feldman SA
    Anaesthesia; 1993 Mar; 48(3):200-1. PubMed ID: 8096371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The onset of rocuronium, but not of vecuronium or mivacurium, is modified by tourniquet inflation.
    Audibert G; Donati F
    Anesth Analg; 1996 Apr; 82(4):848-53. PubMed ID: 8615509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Train-of-four fade and neuromuscular block in rats: a comparison between pancuronium, vecuronium, and rocuronium.
    Itoh H; Shibata K; Nitta S; Kobayashi T
    Can J Anaesth; 2000 Oct; 47(10):950-5. PubMed ID: 11032268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative potency of steroidal neuromuscular blocking drugs and isobolographic analysis of the interaction between rocuronium and other aminosteroids.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Jul; 75(1):37-42. PubMed ID: 7669466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of twitch fade based on slow interaction of nondepolarizing muscle relaxants with the presynaptic receptors.
    Bhatt SB; Amann A; Nigrovic V
    J Pharmacokinet Pharmacodyn; 2006 Aug; 33(4):461-83. PubMed ID: 16752087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is recovery of neuromuscular transmission complete after the use of neostigmine to antagonize block produced by rocuronium, vecuronium, atracurium and pancuronium?
    Baurain MJ; Hoton F; D'Hollander AA; Cantraine FR
    Br J Anaesth; 1996 Oct; 77(4):496-9. PubMed ID: 8942335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Onset of neuromuscular block after tourniquet inflation: comparison of suxamethonium with vecuronium.
    Audibert G; Donati F
    Br J Anaesth; 1995 Oct; 75(4):436-40. PubMed ID: 7488484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fading responses in the evoked EMG after rocuronium in cats.
    Shiraishi H; Suzuki H; Suzuki T; Katsumata N; Ogawa S
    Can J Anaesth; 1992 Dec; 39(10):1099-104. PubMed ID: 1361162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atracurium, cisatracurium, vecuronium and rocuronium in patients with renal failure.
    Della Rocca G; Pompei L; Coccia C; Costa MG; Cecchini V; Vilardi V; Pietropaoli P
    Minerva Anestesiol; 2003; 69(7-8):605-11, 612, 5. PubMed ID: 14564242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of calcium channel blockers with non-depolarising muscle relaxants in vitro.
    Sekerci S; Tulunay M
    Anaesthesia; 1996 Feb; 51(2):140-4. PubMed ID: 8779369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic study of speed of action of various muscle relaxants.
    Min JC; Bekavac I; Glavinovic MI; Donati F; Bevan DR
    Anesthesiology; 1992 Aug; 77(2):351-6. PubMed ID: 1353667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of cold on the recovery of three neuromuscular blocking agents in man.
    England AJ; Wu X; Richards KM; Redai I; Feldman SA
    Anaesthesia; 1996 Mar; 51(3):236-40. PubMed ID: 8712323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine potentiation of neuromuscular blocking agents in guinea-pigs.
    Nitahara K; Kornak P; Nagashima H; Vizi ES; Foldes FF; Dan K
    Br J Anaesth; 2000 Feb; 84(2):245-7. PubMed ID: 10743461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac effects of non-depolarizing neuromuscular blocking agents pancuronium,vecuronium, and rocuronium in isolated rat atria.
    Melnikov AL; Malakhov KY; Helgesen KG; Lathrop DA
    Gen Pharmacol; 1999 Oct; 33(4):313-7. PubMed ID: 10523069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are plasma concentration values necessary for pharmacodynamic modeling of muscle relaxants?
    Fisher DM; Wright PM
    Anesthesiology; 1997 Mar; 86(3):567-75. PubMed ID: 9066322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Newly developed muscle relaxants].
    Fukushima K
    Masui; 1997 Nov; 46 Suppl():S200-4. PubMed ID: 9508579
    [No Abstract]   [Full Text] [Related]  

  • 20. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.